Giant pituitary adenomas (> 4 cm in maximum diameter) represent a significant surgical challenge. Endoscopic endonasal surgery (EES) has recently been introduced as a treatment option for these tumors. The authors present the results of EES for giant adenomas and analyze the advantages and limitations of this technique.
The authors retrospectively reviewed the medical files and imaging studies of 54 patients with giant pituitary adenomas who underwent EES and studied the factors affecting surgical outcome.
Preoperative visual impairment was present in 45 patients (83%) and partial or complete pituitary deficiency in 28 cases (52%), and 7 patients (13%) presented with apoplexy. Near-total resection (> 90%) was achieved in 36 patients (66.7%). Vision was improved or normalized in 36 cases (80%) and worsened in 2 cases due to apoplexy of residual tumor. Significant factors that limited the degree of resection were a multilobular configuration of the adenoma (p = 0.002) and extension to the middle fossa (p = 0.045). Cavernous sinus invasion, tumor size, and intraventricular or posterior fossa extension did not influence the surgical outcome. Complications included apoplexy of residual adenoma (3.7%), permanent diabetes insipidus (9.6%), new pituitary insufficiency (16.7%), and CSF leak (16.7%, which was reduced to 7.4% in recent years). Fourteen patients underwent radiation therapy after EES for residual mass or, in a later stage, for recurrence, and 10 with functional pituitary adenomas received medical treatment. During a mean follow-up of 37.9 months (range 1–114 months), 7 patients were reoperated on for tumor recurrence. Three patients were lost to follow-up.
Endoscopic endonasal surgery provides effective initial management of giant pituitary adenomas with favorable results compared with traditional microscopic transsphenoidal and transcranial approaches.
Abbreviations used in this paper:EES = endoscopic endonasal surgery; GH = growth hormone; GTR = gross-total resection.
CappabiancaPCavalloLMEspositoFDe DivitiisOMessinaADe DivitiisE: Extended endoscopic endonasal approach to the midline skull base: the evolving role of transsphenoidal surgery. Adv Tech Stand Neurosurg33:151–1992008
CappabiancaP, CavalloLM, EspositoF, De DivitiisO, MessinaA, De DivitiisE: Extended endoscopic endonasal approach to the midline skull base: the evolving role of transsphenoidal surgery. 33:151–199, 2008)| false
LosaMMortiniPBarzaghiRRibottoPTerreniMRMarzoliSB: Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. J Neurosurg108:525–5322008
LosaM, MortiniP, BarzaghiR, RibottoP, TerreniMR, MarzoliSB, : Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. 108:525–532, 2008)| false
ZanationAMCarrauRLSnydermanCHGermanwalaAVGardnerPAPrevedelloDM: Nasoseptal flap reconstruction of high flow intraoperative cerebral spinal fluid leaks during endoscopic skull base surgery. Am J Rhinol Allergy23:518–5212009
ZanationAM, CarrauRL, SnydermanCH, GermanwalaAV, GardnerPA, PrevedelloDM, : Nasoseptal flap reconstruction of high flow intraoperative cerebral spinal fluid leaks during endoscopic skull base surgery. 23:518–521, 2009)| false